Related Experiment Video
Updated: Nov 16, 2025

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
Published on: August 17, 2021
Dysregulation of REV-ERBα impairs GABAergic function and promotes epileptic seizures in preclinical models
Tianpeng Zhang1,2,3, Fangjun Yu2, Haiman Xu2
1Institute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, China.
Abstract:
To design potentially more effective therapies, we need to further understand the mechanisms underlying epilepsy. Here, we uncover the role of Rev-erbα in circadian regulation of epileptic seizures. We first show up-regulation of REV-ERBα/Rev-erbα in brain tissues from patients with epilepsy and a mouse model. Ablation or pharmacological modulation of Rev-erbα in mice decreases the susceptibility to acute and chronic seizures, and abolishes diurnal rhythmicity in seizure severity, whereas activation of Rev-erbα increases the animal susceptibility. Rev-erbα ablation or antagonism also leads to prolonged spontaneous inhibitory postsynaptic currents and elevated frequency in the mouse hippocampus, indicating enhanced GABAergic signaling. We also identify the transporters Slc6a1 and Slc6a11 as regulators of Rev-erbα-mediated clearance of GABA. Mechanistically, Rev-erbα promotes the expressions of Slc6a1 and Slc6a11 through transcriptional repression of E4bp4. Our findings propose Rev-erbα as a regulator of synaptic function at the crosstalk between pathways regulating the circadian clock and epilepsy.
Insights
Rev-erbα (a protein) is upregulated in epilepsy and regulates seizure severity. Modulating Rev-erbα impacts seizure susceptibility and synaptic function, offering new therapeutic targets for epilepsy.
Area of Science:
- Neuroscience
- Chronobiology
- Molecular Biology
Background:
- Epilepsy mechanisms require further elucidation for improved therapies.
- Circadian rhythms influence physiological processes, potentially impacting neurological disorders.
Purpose of the Study:
- To investigate the role of Rev-erbα in the circadian regulation of epileptic seizures.
- To explore Rev-erbα's impact on synaptic function and GABAergic signaling in epilepsy.
Main Methods:
- Analysis of Rev-erbα expression in human epilepsy brain tissues and a mouse model.
- In vivo studies involving Rev-erbα ablation or pharmacological modulation in mice.
- Electrophysiological recordings in the mouse hippocampus to assess synaptic currents.
- Identification of GABA transporters regulated by Rev-erbα.
Main Results:
- Rev-erbα is upregulated in epilepsy and its modulation affects seizure susceptibility and diurnal seizure patterns.
- Rev-erbα manipulation alters inhibitory postsynaptic currents and GABAergic signaling in the hippocampus.
- Slc6a1 and Slc6a11 transporters are identified as Rev-erbα-regulated mediators of GABA clearance.
- Rev-erbα influences Slc6a1 and Slc6a11 expression via repression of E4bp4.
Conclusions:
- Rev-erbα plays a critical role in the circadian control of epilepsy.
- Rev-erbα modulates synaptic function by regulating GABAergic signaling.
- Findings suggest Rev-erbα as a potential therapeutic target at the intersection of circadian rhythms and epilepsy.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists

